MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetes

Introduction

The NICE guidelines on type 1 diabetes in adults and type 1 and 2 diabetes in children and young people describe the prevalence, burden of disease, diagnosis and management of type 1 diabetes. The NICE diagnostics guidance on integrated sensor-augmented pump therapy systems states that some people with type 1 diabetes may experience 'disabling hypoglycaemia', which is when hypoglycaemic episodes occur frequently or without warning. Integrated sensor‑augmented insulin pump therapy systems are designed to improve glucose control. The MiniMed 640G was introduced during the development of the NICE diagnostics guidance, which makes recommendations on other integrated sensor‑augmented pump therapy systems.